Morpholinone compounds as factor IXa inhibitors

Details for Australian Patent Application No. 2009322342 (hide)

Owner Schering Corporation Mochida Pharmaceutical Co., Ltd.

Inventors Nishida, Hidemitsu; Saitoh, Fumihiko; Hirabayashi, Tomokazu; Chackalamannil, Samuel; Chan, Tin-Yau; Chelliah, Mariappan V.; Clasby, Martin C.; Dwyer, Michael P.; Greenlee, William J.; Xia, Yan

Agent Spruson & Ferguson

Pub. Number AU-A-2009322342

PCT Pub. Number WO2010/065717

Priority 61/150,955 09.02.09 US; 61/120,328 05.12.08 US; 61/165,214 31.03.09 US; 61/238,455 31.08.09 US

Filing date 3 December 2009

Wipo publication date 10 June 2010

International Classifications

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/4725 (2006.01)

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 265/32 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 267/10 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D 279/06 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

30 June 2011 PCT application entered the National Phase

  PCT publication WO2010/065717 Priority application(s): WO2010/065717

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Mochida Pharmaceutical Co., Ltd.; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009322346-Stem cell cultures

2009322338-Electrochromic optical element having an apodized aperture